ARE YOU LOOKING FOR UNBIASED INFORMATION IN ART?

Conference on Evidence Based Assisted Reproduction Technology

COME AND JOIN IN THE EBART SPIRIT!

What makes the EBART Congress different from other ART conferences?
Our directors and medical professionals provide you with some of the reasons why... Don't miss this opportunity!

Welcome letter

Dear friends and colleagues,

Assisted reproduction is a branch of medicine undergoing very rapid changes. We are frequently faced with the responsibility of deciding whether a particular technique is beneficial to our patients.

Where should we find the information? Evidence-based medicine offers the answer to this question, as we strive to offer the highest standard of care to our patients.

We are delighted to welcome you to Barcelona for the second EBART (evidence-based assisted reproductive technology) conference in April 2018.

Together, we will discuss about clinical IVF, implantation, cycle optimization, genetics, male factor and ethics and society… And a great deal more by applying an evidence-based approach, evaluating current research data and level of evidence!

We encourage you to join us for 2 days of medicine and science, and look forward to seeing you all in a few months.

Directors

  • Amelia Rodríguez-Aranda

    Amelia Rodríguez-Aranda

    Spain

  • Rita Vassena

    Rita Vassena

    Spain

Speakers

  • George Griesinger

    George Griesinger

    Germany

  • Nick Macklon

    Nick Macklon

    Denmark

  • Siladitya Bhattacharya

    Siladitya Bhattacharya

    UK

  • Claudia Spits

    Claudia Spits

    Belgium

Program

  • Day 1

    5 April 2018

    • 08:00 - 08:30

      Registration

    • 08:15 - 08:30

      Opening address

      Amelia Rodríguez-Aranda (Spain) / Rita Vassena (Spain)

    • 08:30 - 09:00

      Keynote lecture: Genetic instability in embryonic development

      Dietrich Egli (USA)

    • 09:00 - 11.00

      Clinical IVF: Techniques and result

      Chairman

      George Griesinger (Germany)

      Too much treating not enough preventing

      Rita Vassena (Spain)

      ICSI: current use based on evidence or abuse? Re-evaluate the trend

      Siladitya Bhattacharya (UK)

      What chance of success in ART is reasonable? When should we stop treatment? Patient autonomy versus evidence based

      René Frydman (France)

      Perinatal outcomes in third party reproduction

      Anna Blázquez (Spain)

    • 11:00 - 11:30

      Coffee break

    • 11:30 -13:30

      Implantation

      Chairman

      Anja Pinborg (Denmark)

      Managing implantation: when desperation clouds reason

      Nick Macklon (Denmark)

      Endometrial NK cells, senescence and implantation

      Paul John Brighton (UK)

      Single embryo transfer. Expectations and reality

      Christina Bergh (Sweden)

    • 13:30 - 15:30

      Lunch break

    • 15:30 - 17:00

      Cycle optimization

      Chairman

      Giovanni Coticchio (Italy) / Karinna Lattes (Spain)

      Blastocyst culture vs. cleavage stage: what system gives higher CPR?

      Aisling Ahlström (Sweden)

      Vitrification as a tool for cycle optimization

      Amelia Rodríguez-Aranda (Spain)

      Freeze-all: better PR or just a matter of safety? A critical appraisal

      Samuel Dos Santos Ribeiro (Belgium)

    • 17:00

      Closing

  • Day 2

    6 April 2018

    • 08:00 - 10:00

      Genetics

      Chairman

      Nick Macklon (Denmark)

      The link between the mitochondrial genome and ART

      Claudia Spits (Belgium)

      What should we do with mosaic embryos

      Nathan Treff (USA)

      Evidence based PGS: an update

      George Griesinger (Germany)

    • 10:00 - 10:30

      Selected oral communication

      Chairman

      Maria Beatrice Dal Canto (Italy) / Eduardo Motta (Brasil)

      3 communications chosen among the submitted abstracts

    • 10:30 - 11:00

      ART in the world: Present data and future perspectives

      Jacques de Mouzon (France)

    • 11:00 - 11:30

      Coffee break

    • 11:30 - 13:30

      Male factor

      Chairman

      Ursula Eichenlaub-Ritter (Germany) / Ignacio Madero (Colombia)

      Proteomic analysis of male factor

      Charles Pineau (France)

      IVF vs. IUI: what should we chose and when

      Anja Pinborg (Denmark)

      Should we care about sperm DNA damage and how?

      Madelon Van Wely (The Netherlands)

    • 13:30 - 15:30

      Lunch break

    • 15:30 - 17:30

      Ethics and society

      Chairman

      Svend Lindenberg (Denmark) / Mauricio Chehin (Brasil)

      Oncofertility: is universal access advisable?

      Richard Anderson (UK)

      Expanded carrier screening: ethical challenges.

      Pascal Borry (Belgium)

      Disclosure of donor conception and the right to know about one’s genetic origin

      Guido Pennings (Belgium)

      Surrogacy in Europe: to allow, to regulate, to forbid?

      Françoise Shenfield (UK)

    • 17:30

      Closing

Location

AXA Auditorium and Convention Center

Avinguda Diagonal, 547, 08029 Barcelona

News

  • Meet the EBART’s Directors

    EBART represents a transparent, open and critical approach to assisted reproduction. EBART will focus on well established treatments and on upcoming therapies and discoveries alike. Do you want to know a little more about our Directors? @RitaVassena Scientific Director of the Eugin Group Member of the ESHRE Executive Committee PhD from the University of Milan Author…

  • Call for Abstract! Outstanding opportunity for you to be the chosen one

    Do you have interesting data to present at the EBART Congress 2018? If you do, don’t miss this opportunity. We invite you to submit your latest research work for presentation in front of an international audience. Hundreds of doctors, researchers and scientists will be attending the congress. This is an oustanding opportunity for you. Check…

  • Last days to enjoy the Early Bird Registration

    This year, the topics to be discussed at the EBART Congress are exceptional. If you don’t believe us, check the program. Ready to learn more about Assisted Reproduction Technology? You are lucky, you have 2 more days to enjoy the Early Bird Registration! View special price.

Registration

Register now

Organizers